AXXELIS will work alongside your team to develop in-depth valuation models to help inform strategic decision-making and investment making. Building on our experience, we go well beyond risk-adjusted NPV to provide a holistic view of the asset you are evaluating.
Investment evaluation
What are we really good at?
Research & Development
- Leadership resourcing
- Therapy area expertise consultations
- Review of Research & Development asset stage gate strategies
- Start-up funding and organisation
- Accelerating digital transformation and patient centricity across Research & Development
- Integrated pharmacometrics analysis
- Investment evaluation
Business Consulting
Request Consultation
We look forward to discussing your business ambitions, simply complete the form below with an overview of your requirements and we’ll be in touch.
Call us today
CH: +41 79 763 90 18
UK: +44 7789 964468
US: +1 917 604 46 91
Axxelis Lightning Exchange #5 – ‘A journey against all odds – the first mRNA splice modifier to market’
On Thursday 9th December the highly anticipated 4th Axxelis Lightning Exchange event was held. The subject matter this time around was the fascinating and expansive topic; ‘The convergence of health and technology: more than a gadget’.
Axxelis Lightning Exchange #4 – ‘The convergence of health and technology: more than a gadget’
On Thursday 9th December the highly anticipated 4th Axxelis Lightning Exchange event was held. The subject matter this time around was the fascinating and expansive topic; ‘The convergence of health and technology: more than a gadget’.
Axxelis Lightning Exchange #3 – ‘TRUST in Expert Networks.’
“To show trust is to behave as if the future were certain” – Luhmann. Wednesday 29th September saw our highly anticipated third Axxelis Lightning Exchange event take place.